Developer docs
API playgroundTry for free, no card

Search company profiles

Porzio Life Sciences

Full company profile

uuid000nfsg

Namestring
Porzio Life Sciences
Legal namestring
Porzio Life Sciences, LLC
Company typeenum
Private
Founded yearint
2004
Descriptiontext

Porzio Life Sciences is a US-based, privately-held provider of cloud-based compliance software for the life sciences industry, headquartered in Morristown, NJ and operating primarily through its MediSpend platform. The company serves more than 400 pharmaceutical, biotechnology, and medical technology organizations globally, addressing regulatory and commercial compliance workflows including spend transparency reporting under the US Sunshine Act and international equivalents, clinical trial data disclosure, medical affairs scientific exchange (Beacon), field sales coaching (iCoach/iCoachFirst), third-party due diligence, fair market value management, and revenue/pricing transparency (iContracts Revenue Management Suite, Price Transparency Reporting).

The underlying technology is a multi-tenant SaaS platform delivered via partnerships with AWS, Google Cloud, Microsoft, and Salesforce, with enterprise identity management supported through Okta SSO across both US and EU production environments. The product suite is organized into five solution families — Regulatory Science, Commercial Compliance, Medical Affairs, Field Enablement, and Revenue Management — and is sold through a consultative, direct enterprise sales motion with quote-based annual subscription pricing. Porzio Life Sciences is a wholly-owned subsidiary of RLDatix, a strategic operating company in healthcare governance, risk, and compliance, and has historically integrated acquired point solutions (formerly MMIS, Inc., doing business as Medispend) into a unified offering.

Short descriptiontext

Porzio Life Sciences, operating through its MediSpend platform, provides cloud-based compliance software to 400+ pharmaceutical, biotechnology, and medical technology companies globally, covering spend transparency, medical affairs, field enablement, and revenue management as an RLDatix subsidiary.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersMorristown, United States
HQ citystring
Morristown
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
life sciences compliance software, spend transparency reporting, clinical data disclosure, pharma regulatory compliance, medical affairs software
NAICS code1 code
  • Software Publishers5132
SIC code1 code
  • Services-Prepackaged Software7372
Product category
Life Sciences Compliance Software
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Enterprise SaaS Subscriptions
TypeSubscription Recurring
Description

Cloud-based software solutions sold to pharmaceutical, biotech and medical technology companies on a subscription basis. The company serves 400+ enterprise customers globally with compliance management software.

medispend.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations
Pricing details1 tier
1Enterprise custom pricing
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based pricing tailored to organization size and solution requirements. Discovery meeting required to determine specific needs and pricing.

medispend.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 5 records shown
1MedispendIQ
Description

Intelligence and analytics platform for life sciences compliance data

medispend.com
+4 more records
Core offering1 text field

Porzio Life Sciences sells the Medispend cloud-based SaaS platform, a suite of compliance and commercial operations software modules for pharmaceutical, biotechnology, and medical technology companies. The suite covers regulatory science (clinical transparency, confidential information management), commercial compliance (spend transparency, stakeholder engagement, third-party due diligence, FMV data, global compliance digest), medical affairs (Beacon closed loop scientific exchange, events and grants management), field enablement (iCoach coaching), and revenue management (iContracts, price transparency). The platform is sold via annual enterprise subscriptions to 400+ life sciences customers worldwide.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Porzio Life Sciences, through its MediSpend platform, offers a comprehensive suite of cloud-based compliance software solutions for life sciences organizations. The core MediSpend platform provides integrated modules across Regulatory Science (Clinical Transparency, Confidential Information Management), Commercial Compliance (Spend Transparency, Stakeholder Engagement, Global Compliance Digest, Third-Party Due Diligence, FMV Data Management), Medical Affairs (Events Management, Grants/IIS Management, Beacon Closed Loop Scientific Exchange), Field Enablement (iCoach/iCoachFirst), and Revenue Management (iContracts Revenue Management Suite, Price Transparency). Additional branded products include MediSpendIQ for analytics, Global Spend Transparency for disclosure reporting, and Third Party Engagement solutions for US and EU markets. More than 400 pharmaceutical, biotech, and medical technology companies use these solutions to reduce compliance risk, improve customer engagements, optimize operations, and make data-driven decisions.

Product and service12 records
1Medispend Platform
CategoryCore Compliance Platform
Description

Integrated cloud-based compliance management platform serving pharmaceutical, biotech, and medical technology companies with modules spanning the full compliance lifecycle.

2MediSpendIQ
CategoryCompliance Analytics
Description

Analytics and intelligence module on the Medispend platform that turns compliance and commercial data into insights for life sciences business decisions.

3Beacon Closed Loop Scientific Exchange
CategoryMedical Affairs Software
Description

Closed loop scientific exchange platform that enables medical affairs teams to manage healthcare professional engagements, scientific dialogue, grants, and events, connecting insights across interactions.

4iCoach / iCoachFirst
CategoryField Enablement Software
Description

Field enablement and sales coaching platform providing compliance-first feedback and continuous coaching for life sciences field sales and medical teams.

5iContracts Revenue Management Suite
CategoryRevenue Management Software
Description

Revenue management suite that helps life sciences companies navigate pricing regulations, manage revenue flows, and enforce pricing transparency.

6Global Spend Transparency (GST)
CategorySpend Transparency Reporting
Description

Spend transparency reporting solution for compliance with global disclosure regulations, including U.S. Sunshine Act requirements.

7Price Transparency Reporting
CategoryPrice Transparency Reporting
Description

Pricing transparency reporting solution for managing and reporting on price-related compliance requirements in life sciences.

8Third Party Engagement (TPE)
CategoryThird-Party Due Diligence
Description

Third-party due diligence solution for managing stakeholder engagement compliance across US and EU markets.

9Global Compliance Digest
CategoryCompliance Intelligence
Description

Compliance intelligence tool providing centralized oversight and actionable insights on global commercial activity compliance for life sciences organizations.

10Confidential Information Management (CIM)
CategoryRegulatory Science Software
Description

Solution for managing confidential information and sensitive data within regulatory science submissions and clinical transparency processes.

11Spend Transparency
CategorySpend Transparency Reporting
Description

Spend transparency solution for complying with spend disclosure regulations and maintaining compliance across global commercial activities.

12Clinical Transparency
Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeOthers
Description

Porzio Life Sciences is an RLDatix Company. RLDatix provides governance, risk management and compliance solutions for healthcare organizations. This is a parent-subsidiary relationship where Porzio Life Sciences operates as part of the RLDatix ecosystem.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

API detail
Has APIbool
No

Docs URL, Description

Integration5 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries6 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Porzio Life Sciences

Life Sciences Compliance Softwareporziolifesciences.com

Porzio Life Sciences, operating through its MediSpend platform, provides cloud-based compliance software to 400+ pharmaceutical, biotechnology, and medical technology companies globally, covering spend transparency, medical affairs, field enablement, and revenue management as an RLDatix subsidiary.

What Porzio Life Sciences does

Porzio Life Sciences is a US-based, privately-held provider of cloud-based compliance software for the life sciences industry, headquartered in Morristown, NJ and operating primarily through its MediSpend platform. The company serves more than 400 pharmaceutical, biotechnology, and medical technology organizations globally, addressing regulatory and commercial compliance workflows including spend transparency reporting under the US Sunshine Act and international equivalents, clinical trial data disclosure, medical affairs scientific exchange (Beacon), field sales coaching (iCoach/iCoachFirst), third-party due diligence, fair market value management, and revenue/pricing transparency (iContracts Revenue Management Suite, Price Transparency Reporting).

The underlying technology is a multi-tenant SaaS platform delivered via partnerships with AWS, Google Cloud, Microsoft, and Salesforce, with enterprise identity management supported through Okta SSO across both US and EU production environments. The product suite is organized into five solution families — Regulatory Science, Commercial Compliance, Medical Affairs, Field Enablement, and Revenue Management — and is sold through a consultative, direct enterprise sales motion with quote-based annual subscription pricing. Porzio Life Sciences is a wholly-owned subsidiary of RLDatix, a strategic operating company in healthcare governance, risk, and compliance, and has historically integrated acquired point solutions (formerly MMIS, Inc., doing business as Medispend) into a unified offering.

Porzio Life Sciences firmographics

Firmographics
Name
Porzio Life Sciences
Legal name
Porzio Life Sciences, LLC
Website
https://porziolifesciences.com
Company type
Private
Founded year
2004
Operating status
Operating
Headcount range
51–100 employees
Short description
Porzio Life Sciences, operating through its MediSpend platform, provides cloud-based compliance software to 400+ pharmaceutical, biotechnology, and medical technology companies globally, covering spend transparency, medical affairs, field enablement, and revenue management as an RLDatix subsidiary.
Ownership category
akta.pro rank

Where Porzio Life Sciences is headquartered

Location

Headquarters

HQ city
Morristown
HQ country
United States
HQ region
North America

Markets served

Porzio Life Sciences business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. Enterprise SaaS Subscriptions: Cloud-based software solutions sold to pharmaceutical, biotech and medical technology companies on a subscription basis. The company serves 400+ enterprise customers globally with compliance management software.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise custom pricing

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Porzio Life Sciences product offering

Product offering

Core offering

Porzio Life Sciences sells the Medispend cloud-based SaaS platform, a suite of compliance and commercial operations software modules for pharmaceutical, biotechnology, and medical technology companies. The suite covers regulatory science (clinical transparency, confidential information management), commercial compliance (spend transparency, stakeholder engagement, third-party due diligence, FMV data, global compliance digest), medical affairs (Beacon closed loop scientific exchange, events and grants management), field enablement (iCoach coaching), and revenue management (iContracts, price transparency). The platform is sold via annual enterprise subscriptions to 400+ life sciences customers worldwide.

Product overview

Porzio Life Sciences, through its MediSpend platform, offers a comprehensive suite of cloud-based compliance software solutions for life sciences organizations. The core MediSpend platform provides integrated modules across Regulatory Science (Clinical Transparency, Confidential Information Management), Commercial Compliance (Spend Transparency, Stakeholder Engagement, Global Compliance Digest, Third-Party Due Diligence, FMV Data Management), Medical Affairs (Events Management, Grants/IIS Management, Beacon Closed Loop Scientific Exchange), Field Enablement (iCoach/iCoachFirst), and Revenue Management (iContracts Revenue Management Suite, Price Transparency). Additional branded products include MediSpendIQ for analytics, Global Spend Transparency for disclosure reporting, and Third Party Engagement solutions for US and EU markets. More than 400 pharmaceutical, biotech, and medical technology companies use these solutions to reduce compliance risk, improve customer engagements, optimize operations, and make data-driven decisions.

Differentiator

Problem solved

Functional benefit

Brands

  • MedispendIQ: Intelligence and analytics platform for life sciences compliance data
  • iCoach
  • Beacon
  • iContracts
  • Porzio Suite

Products and services

  • Medispend Platform Integrated cloud-based compliance management platform serving pharmaceutical, biotech, and medical technology companies with modules spanning the full compliance lifecycle.
  • MediSpendIQ Analytics and intelligence module on the Medispend platform that turns compliance and commercial data into insights for life sciences business decisions.
  • Beacon Closed Loop Scientific Exchange Closed loop scientific exchange platform that enables medical affairs teams to manage healthcare professional engagements, scientific dialogue, grants, and events, connecting insights across interactions.
  • iCoach / iCoachFirst Field enablement and sales coaching platform providing compliance-first feedback and continuous coaching for life sciences field sales and medical teams.
  • iContracts Revenue Management Suite Revenue management suite that helps life sciences companies navigate pricing regulations, manage revenue flows, and enforce pricing transparency.
  • Global Spend Transparency (GST) Spend transparency reporting solution for compliance with global disclosure regulations, including U.S. Sunshine Act requirements.
  • Price Transparency Reporting Pricing transparency reporting solution for managing and reporting on price-related compliance requirements in life sciences.
  • Third Party Engagement (TPE) Third-party due diligence solution for managing stakeholder engagement compliance across US and EU markets.
  • Global Compliance Digest Compliance intelligence tool providing centralized oversight and actionable insights on global commercial activity compliance for life sciences organizations.
  • Confidential Information Management (CIM) Solution for managing confidential information and sensitive data within regulatory science submissions and clinical transparency processes.
  • Spend Transparency Spend transparency solution for complying with spend disclosure regulations and maintaining compliance across global commercial activities.
  • Clinical Transparency

Companies that use Porzio Life Sciences

Customer profile

Segments3 records

Ideal customer profiles3 records

Porzio Life Sciences technology and API

Technology

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration5 records

Feature5 records

Porzio Life Sciences partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • RLDatixcoreOthersPorzio Life Sciences is an RLDatix Company. RLDatix provides governance, risk management and compliance solutions for healthcare organizations. This is a parent-subsidiary relationship where Porzio Life Sciences operates as part of the RLDatix ecosystem.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Porzio Life Sciences competitors and assessment

Company assessment

Market position

Weaknesses4 records

Competitive moat5 records

Customer concentration

Porzio Life Sciences social profiles

Digital presence

Porzio Life Sciences financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Porzio Life Sciences leadership team

Management profile

Number of profiles

Porzio Life Sciences subsidiaries and ownership

Company hierarchy

Subsidiaries6 records

Porzio Life Sciences funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Porzio Life Sciences M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Porzio Life Sciences

What does Porzio Life Sciences do?

Porzio Life Sciences sells the Medispend cloud-based SaaS platform, a suite of compliance and commercial operations software modules for pharmaceutical, biotechnology, and medical technology companies. The suite covers regulatory science (clinical transparency, confidential information management), commercial compliance (spend transparency, stakeholder engagement, third-party due diligence, FMV data, global compliance digest), medical affairs (Beacon closed loop scientific exchange, events and grants management), field enablement (iCoach coaching), and revenue management (iContracts, price transparency). The platform is sold via annual enterprise subscriptions to 400+ life sciences customers worldwide.

Is Porzio Life Sciences a public or private company?

Porzio Life Sciences is a private company. It is classified as corporate owned and is currently operating.

When was Porzio Life Sciences founded?

Porzio Life Sciences was founded in 2004. It employs 51 to 100 people.

Where is Porzio Life Sciences based?

Porzio Life Sciences is headquartered in Morristown, United States, in the North America region.

How does Porzio Life Sciences make money?

One revenue line is on record: enterprise SaaS Subscriptions.

Does Porzio Life Sciences have an API?

No public API is recorded for Porzio Life Sciences.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireRLDATIX LIFE SCIENCES: A PIONEERING MERGER OF PORZIO LIFE SCIENCES, iCONTRACTS, AND iCOACHFIRSTRLDatix Life Sciences announced the integration of Porzio Life Sciences, iContracts, and iCoachFirst, forming a new business unit. The combined entity offers compliance, revenue management, and coaching services for the life sciences industry. The launch aims to drive innovation and support safer care delivery.PR NewswireRLDatix to Acquire Porzio Life SciencesRLDatix announced a definitive agreement to acquire Porzio Life Sciences, a market leader in compliance solutions for the life sciences industry. This acquisition expands RLDatix's capabilities in governance, risk, and compliance (GRC) by integrating Porzio's regulatory expertise and software tools into its existing global platform. The transaction is scheduled to close early next month, subject to customary conditions.PR NewswireAHM In London This Fall Focusing On Compliant HCP Interactions For European Life SciencesAHM, a provider of software and service solutions for healthcare professional (HCP) interaction management, is hosting and exhibiting at two compliance-focused events in the UK in October 2016: a seminar in Windsor on October 4th and the Pharma Compliance Conference in London on October 5-6th. The events address compliance with EFPIA guidelines and transparency requirements for managing HCP interactions, with solution leaders Cvent and Porzio Life Sciences participating as presenters. AHM's outreach comes as European healthcare organizations face increasing regulatory oversight under the newly implemented EFPIA Guidelines, which represent 1,900 European HCOs.